Naltrexone Hydrochloride
Products in Health Canada’s databases that list Naltrexone Hydrochloride as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 6
- 5 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 19
- Products in all
- 6
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| APO-NALTREXONE (50 MG) | 02444275 | Marketed | Apotex Inc. | |
| CONTRAVE (8 MG) | 02472945 | Marketed | Bausch Health, Canada Inc. | |
| NALTREXONE HYDROCHLORIDE TABLETS USP (50 MG) | 02451883 | Marketed | Sterinova Inc. | |
| REVIA (50 MG) | 02213826 | Marketed | Teva Canada Limited | |
| RPC-NALTREXONE (50 MG) | 02558343 | Approved | Rusan Pharma Canada Inc. | |
| REVIA - TAB 50MG (50 MG) | 02158655 | Cancelled Post Market | Dupont Merck Pharma Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- CONTRAVEDecember 24, 2025 · NOC 36628
- CONTRAVESeptember 19, 2025 · NOC 36037
- RPC-NALTREXONEJune 17, 2025 · NOC 35529
- CONTRAVEAugust 23, 2023 · NOC 31477
- CONTRAVEJuly 5, 2022 · NOC 28522
- CONTRAVEMarch 3, 2022 · NOC 27702
- CONTRAVESeptember 24, 2021 · NOC 26738
- REVIAJuly 16, 2020 · NOC 23919
- REVIAAugust 23, 2018 · NOC 21237
- CONTRAVEFebruary 13, 2018 · NOC 20469
- NALTREXONE HYDROCHLORIDE TABLETS USPFebruary 11, 2016 · NOC 17771
- APO-NALTREXONEAugust 5, 2015 · NOC 17169
- REVIAMay 5, 2015 · NOC 16872
- REVIAMay 13, 2003 · NOC 3392
- REVIANovember 22, 2001 · NOC 2462
- REVIAAugust 21, 1998 · NOC 3080
- REVIAFebruary 28, 1996 · NOC 4565
- REVIADecember 20, 1995 · NOC 5170
- REVIAMarch 23, 1995 · NOC 5195